Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation

Deborah J. Levine, Allan R. Glanville, Christina Aboyoun, John Belperio, Christian Benden, Gerald J. Berry, Ramsey Hachem, Don Hayes, Desley Neil, Nancy L. Reinsmoen, Laurie D. Snyder, Stuart Sweet, Dolly Tyan, Geert Verleden, Glen Westall, Roger D. Yusen, Martin Zamora, Adriana Zeevi

Research output: Contribution to journalArticlepeer-review

129 Scopus citations

Abstract

Antibody-mediated rejection (AMR) is a recognized cause of allograft dysfunction in lung transplant recipients. Unlike AMR in other solid-organ transplant recipients, there are no standardized diagnostic criteria or an agreed-upon definition. Hence, a working group was created by the International Society for Heart and Lung Transplantation with the aim of determining criteria for pulmonary AMR and establishing a definition. Diagnostic criteria and a working consensus definition were established. Key diagnostic criteria include the presence of antibodies directed toward donor human leukocyte antigens and characteristic lung histology with or without evidence of complement 4d within the graft. Exclusion of other causes of allograft dysfunction increases confidence in the diagnosis but is not essential. Pulmonary AMR may be clinical (allograft dysfunction which can be asymptomatic) or sub-clinical (normal allograft function). This consensus definition will have clinical, therapeutic and research implications.

Original languageEnglish (US)
Pages (from-to)397-406
Number of pages10
JournalJournal of Heart and Lung Transplantation
Volume35
Issue number4
DOIs
StatePublished - Apr 1 2016

Keywords

  • HLA antibodies
  • allograft dysfunction
  • lung transplantation
  • rejection

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Fingerprint Dive into the research topics of 'Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation'. Together they form a unique fingerprint.

Cite this